MedDataX Logo

Follicular Fluid Fetuins in in Vitro Fertilization

NCT ID: NCT04201847

Last Updated: 2020-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-20

Study Completion Date

2019-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate whether follicular fluid concentrations of fetuin A and fetuin B are associated with the clinical pregnancy and live birth rates in in vitro fertilization (IVF) cycles.Twenty-nine women with poor ovarian reserve (poor responders) and 33 women with polycystic ovary syndrome (hyper responders) who consecutively underwent IVF at a private hospital between May 2018 and February 2019.Fetuin A and fetuin B in follicular fluid were significantly lower in women who had clinical pregnancy than women who had no clinical pregnancy (p=0.001 for both)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility Infertility, Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Infertile women with normal ovarian reserve

Infertile women with normal ovarian reserve will be included.

Group Type ACTIVE_COMPARATOR

Serum test

Intervention Type DIAGNOSTIC_TEST

Serum Fetuin A and fetuin B

Infertile women with high ovarian reserve

Infertile women with high ovarian reserve will be included.

Group Type ACTIVE_COMPARATOR

Serum test

Intervention Type DIAGNOSTIC_TEST

Serum Fetuin A and fetuin B

Infertile women with poor ovarian reserve

Infertile women with poor ovarian reserve will be included.

Group Type ACTIVE_COMPARATOR

Serum test

Intervention Type DIAGNOSTIC_TEST

Serum Fetuin A and fetuin B

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Serum test

Serum Fetuin A and fetuin B

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

FOLLICULAR FETUIN B LEVELS IN IVF

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Poor ovarian reserve patients and patient with polycystic ovary syndrome

Exclusion Criteria

Normoresponders
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Samsun Education and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Samettin Çelik

Medical Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Samettin Çelik

Samsun, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KAEK-2019/4/27

Identifier Type: -

Identifier Source: org_study_id